|
| Mean Recommendation (this week): | 2.1 | | Mean Recommendation (last week): | 2.2 | | Change: | -0.1 |
|
| Mean Target: | 35.36 | | Median Target: | 37.50 | | High Target: | 44.00 | | Low Target: | 17.00 | | No. of Brokers: | 14 |
|
|
|
|
|
| UPGRADES & DOWNGRADES HISTORY |
| Date | Research Firm | Action | From | To | | 20-Jul-09 | Caris & Company | Initiated | | Sell | | 25-Jun-09 | Hapoalim | Initiated | | Outperform | | 1-Apr-09 | FTN Equity Capital | Downgrade | Buy | Sell | | 12-Mar-09 | FTN Equity Capital | Initiated | | Buy | | 14-Nov-08 | Stanford Research | Initiated | | Buy | | 10-Nov-08 | Leerink Swann | Initiated | | Outperform | | 3-Nov-08 | Roth Capital | Upgrade | Sell | Hold | | 3-Nov-08 | Deutsche Securities | Upgrade | Hold | Buy | | 30-Sep-08 | Brean Murray | Initiated | | Sell | | 11-Sep-08 | Oppenheimer | Initiated | | Outperform |
|
Data provided by Briefing.com - Take a Free Trial Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights. |
|
| Current Month | Last Month | Two Months Ago | Three Months Ago | | Strong Buy | 6 | 6 | 6 | 6 | | Buy | 4 | 4 | 4 | 5 | | Hold | 3 | 3 | 3 | 3 | | Underperform | 0 | 0 | 0 | 0 | | Sell | 2 | 2 | 2 | 2 |
|
|
|